$0.47
(Market cap
$1,109 Mln
Revenue (TTM)
$340 Mln
P/E Ratio
276.4
P/B Ratio
3.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
19.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0.1
-
Face value
--
-
Shares outstanding
50,143,984
10 Years Aggregate
CFO
$147.57 Mln
EBITDA
$140.50 Mln
Net Profit
$84.26 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
STAAR Surgical (STAA)
| 2.1 | -3.2 | -17.3 | -15.0 | -18.2 | -31.6 | 10.2 |
|
BSE Sensex
| -10.1 | -2.5 | 2.0 | -5.0 | 5.2 | 5.7 | 10.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
STAAR Surgical (STAA)
| -4.9 | -22.0 | -35.7 | -46.8 | 15.2 | 125.2 | 10.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
STAAR Surgical (STAA)
|
23.6 | 1,108.7 | 339.6 | 3.8 | 6.8 | 1.1 | 276.4 | 3.1 |
| 63.2 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 15.2 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 59.4 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 180.4 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 101.0 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 88.6 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.1 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 169.6 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout STAAR Surgical (STAA)
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens... product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Read more
-
President, CEO & Chairman
Mr. Thomas G. Frinzi
-
President, CEO & Chairman
Mr. Thomas G. Frinzi
-
Headquarters
Lake Forest, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for STAAR Surgical (STAA)
What is the current share price of STAAR Surgical Company (STAA) Today?
The share price of STAAR Surgical Company (STAA) is $23.58 (NASDAQ) as of 03-Sep-2026 16:00 EDT. STAAR Surgical Company (STAA) has given a return of -18.19% in the last 3 years.
What is the current PB & PE ratio of STAAR Surgical Company (STAA)?
The P/E ratio of STAAR Surgical Company (STAA) is 276.38 times as on 28-Aug-2026, a 522 premium to its peers’ median range of 44.46 times.
The P/B ratio of STAAR Surgical Company (STAA) is 3.07 times as on 28-Aug-2026, a 19 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-14.23 |
3.33 |
2024 |
-59.22 |
3.01 |
2024 |
-- |
-- |
2023 |
71.99 |
3.98 |
2023 |
-- |
-- |
What is the 52 Week High and Low of STAAR Surgical Company (STAA)?
The 52-week high and low of STAAR Surgical Company (STAA) are Rs 35.87 and Rs 15.59 as of 04-Sep-2026.
What is the market cap of STAAR Surgical Company (STAA)?
STAAR Surgical Company (STAA) has a market capitalisation of $ 1,109 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in STAAR Surgical Company (STAA)?
Before investing in STAAR Surgical Company (STAA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.